Specialty: Oncology, Hematology
Immunohistochemical indices of some types of viruses among benign tumors of salivary glandsMalanchuk V.O. Brodetskyi I.S. Krotevych M.S. 3(2) (131) – V/VI 2019 15
Features of diagnosis and surgical treatment of intraductal neoplasms of the breastAksenov A.A. Aksenova E.G. Belonenko G.A. Smolanka I.I. 2(1) (130) – III/IV 2019 96
Characteristcs of the vascular pattern of mammary gland on the thermography scanKovalchuk S.I. Dunaevskiy V.I. Kovalchuk I.S. Kotovskiy V.I.... 2(2) (130) – III/IV 2019 142
Prospects of the development of the mutation status in children with acute lymphoblastic leukemiaVynnytska O.A. Dorosh O.I. Dubey L.Ya. Dubey N.V. 5(2) (127) – IX/X 2018 172
Actuality of application of neoadjuvant chemotherapy in the treatment of cervical cancerPryimak V.V. Renkas O.P. Svintsitsky V.S. 4(2) (126) – VII/VIII 2018 117
Analysis of the activities of Ukraine’s blood service activities in 2017Aladyevа O.M. Perekhrestenko P.M. Samus V.M. 3(2) (125) – V/VI 2018 247
General characteristics of the health-related quality of life in children with severe hemophilia A in UkraineMarkin A.I. 3(2) (125) – V/VI 2018 112
Phthalates — questions of biotoxicity for the human bodyGertsiuk M.M. Deyev V.A. Kubashko А.V. 1(2) (123) – I/II 2018 372
Modern metods for laboratory detection of lupus anticoagulant in patients with antiphospholipid syndromeKrasivska V.V. Stasyshyn O.V. 1(1) (123) – I/II 2018 270
Historical, ethical and legal aspects of autopsy. Experience of Ukraine and other countriesDyadyk О.О. Lysak A.V. Pustovit S.V. 5 (121) – IX/X 2017 491
Electronic cigarettes: pros and cons
Prognostic value of systemic inflammation markers in non-Hodgkin lymphoma and chronic lymphocytic leukemiaDanysh O.Y. Dzis Y.I. Dzis I.Y. Tomashevska O.Ya. 3 (119) – V/VI 2017 205
The modern approach to the diagnosis of renal cystsVozianov S.O. Kuprin D.I. Shmatyuk T.I. 3 (119) – V/VI 2017 1033
Detection of co-morbidities at thermal imaging of mammary glandsHulchiy M V Dunaevskiy V.I. Kotovskiy V.I. Nasarchuk S.S.... 2 (118) – III/IV 2017 312
An innovative breakthrough in cancer immunotherapy: potential of pembrolizumabMaltsev D.V. 6 (116) – XI/XII 2016 1464
